This is consistent with our results suggesting that Fbp1 may be involved in the pathogenesis of asthma and that its elevated level in epithelial cells following ovalbumin challenge or IL‐4 or IL‐13 treatment may be a detrimental mechanism inducing injury in bronchial epithelial cells. This evidence concerns the gene IL13 and asthma.